Human hepatocytes are protected from ethanol-induced cytotoxicity by DADS via CYP2E1 inhibition

Toxicol Lett. 2006 Jun 1;163(3):242-9. doi: 10.1016/j.toxlet.2005.11.003. Epub 2005 Dec 13.

Abstract

We investigated the protective effects of diallyl disulfide (DADS), a potent inhibitor of cytochrome P450 2E1 (CYP2E1), on ethanol-induced toxicity in human hepatocytes. We found a clear dose-dependent response between ethanol and CYP2E1 activity. The ethanol-dependent CYP2E1 enzyme activity and protein expression, lactate dehydrogenase and aspartate transaminase release, malondialdehyde formation and caspase-3 activity decreased dramatically in the presence of DADS. Furthermore, DADS increased the hepatocellular glutathione (GSH) content and prevented the ethanol-dependent cellular GSH depletion. Our data show that DADS reduces ethanol-induced toxicity in human hepatocytes by reducing CYP2E1 activity and/or stabilizing the cellular GSH content, which might be of therapeutic interest.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Allyl Compounds / pharmacology*
  • Aspartate Aminotransferases / metabolism
  • Blotting, Western
  • Caspase 3
  • Caspases / metabolism
  • Cytochrome P-450 CYP2E1 / metabolism
  • Cytochrome P-450 CYP2E1 Inhibitors*
  • Enzyme Activation
  • Enzyme Inhibitors / pharmacology*
  • Ethanol / toxicity*
  • Glutathione / metabolism
  • Hepatocytes / drug effects
  • Hepatocytes / enzymology
  • Hepatocytes / metabolism
  • Humans
  • L-Lactate Dehydrogenase / metabolism
  • Liver / drug effects*
  • Liver / enzymology
  • Liver / metabolism
  • Malondialdehyde / metabolism
  • Sulfides / pharmacology*

Substances

  • Allyl Compounds
  • Cytochrome P-450 CYP2E1 Inhibitors
  • Enzyme Inhibitors
  • Sulfides
  • Ethanol
  • Malondialdehyde
  • allyl sulfide
  • L-Lactate Dehydrogenase
  • Cytochrome P-450 CYP2E1
  • Aspartate Aminotransferases
  • CASP3 protein, human
  • Caspase 3
  • Caspases
  • Glutathione